MiR-155 was also reported to attenuate the formation of foam cells in coronary atherosclerosis and relieves the chronic inflammation by inhibiting calcium-regulated heat stable protein 1 (CARHSP1) and tumor necrosis factor alpha (TNF-α) (39). Here, TNF is linked to coronary atherosclerosis.